INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

WELLINGTON MANAGEMENT GROUP LLP's Holding History (CIK: 0000902219)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 81,971 Value ($000) $1,101 Avg Close — Range —
Q4 2022
Shares 84,463 Value ($000) $1,045 Avg Close — Range —
Q3 2022
Shares 89,412 Value ($000) $1,247 Avg Close — Range —
Q2 2022
Shares 94,376 Value ($000) $1,304 Avg Close — Range —
Q1 2022
Shares 94,376 Value ($000) $1,536 Avg Close — Range —
Q4 2021
Shares 95,605 Value ($000) $1,557 Avg Close — Range —
Q4 2019
Shares 272,893 Value ($000) $33,817 Avg Close — Range —
Q3 2019
Shares 23,372 Value ($000) $1,551 Avg Close — Range —
Q2 2019
Shares 17,584 Value ($000) $1,399 Avg Close — Range —
Q1 2019
Shares 4,949 Value ($000) $553 Avg Close — Range —
Q2 2018
Shares 5,816 Value ($000) $488 Avg Close — Range —
Q3 2014
Shares 1,600 Value ($000) $379 Avg Close — Range —
Q2 2014
Shares 1,900 Value ($000) $450 Avg Close — Range —
Q1 2014
Shares 10,015 Value ($000) $3,303 Avg Close — Range —
Q2 2013
Shares 81,000 Value ($000) $3,632 Avg Close — Range —